← Return to Hello, I joined today to get help in deciding what medication to begin
DiscussionHello, I joined today to get help in deciding what medication to begin
Osteoporosis & Bone Health | Last Active: Aug 11 10:11pm | Replies (70)Comment receiving replies
Replies to "You can tell him it's not forever. Forteo may very well make it possible for him..."
https://www.pharmaceutical-technology.com/analyst-comment/tymlos-outperforms-teriparatide-real-world-fracture-analysis/
Radius Pharmaceuticals presented real-world evidence at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases on 12 April 2024, demonstrating that Tymlos therapy resulted in a lower incidence of hip and nonvertebral fractures compared to teriparatide therapy in women with osteoporosis aged 50 and older.
The analysis was based on over 18 months of treatment data involving 43,352 patients, and highlighted Tymlos’ efficacy and safety profile as an important treatment option for osteoporosis management.
Despite limitations in the real-world evidence, the study supported Tymlos’ value in reducing fracture risk, further solidifying its role in addressing osteoporosis.